Your browser doesn't support javascript.
loading
Detection of an EML4-ALK fusion mutation secondary to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer: a case report.
Ren, Ke-Hui; Qin, Wen-Wen; Wang, Yun; Peng, Jing-Cui; Hu, Wen-Xia.
Afiliación
  • Ren KH; Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital), Shijiazhuang, China.
  • Qin WW; Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital), Shijiazhuang, China.
  • Wang Y; Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital), Shijiazhuang, China.
  • Peng JC; Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital), Shijiazhuang, China.
  • Hu WX; Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital), Shijiazhuang, China.
Ann Palliat Med ; 11(7): 2503-2509, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35927783
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Ann Palliat Med Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Ann Palliat Med Año: 2022 Tipo del documento: Article País de afiliación: China